Amadeus led a €15m seed round in iPremom, a molecular diagnostics company using cfRNA blood tests for first-trimester prediction of pregnancy complications, with participation from Asabys Partners and APEX Ventures.
iPremom is a medical FemTech company created to translate our scientific knowledge into the development of molecular tests for the early diagnosis of gestational diseases, such as preeclampsia
iPremom is a medical FemTech company created to translate our scientific knowledge into the development of molecular tests for the early diagnosis of gestational diseases, such as preeclampsia.